Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Am. J. Respir. Crit. Care Med. 179, 984-991 (2009)
Rationale: The effects of ultrafine particle inhalation on allergic airway inflammation are of growing interest. The mechanisms underlying these effects are currently under investigation. Objectives: To investigate the role of oxidative stress on the adjuvant activity of inhaled elemental carbon ultrafine particles (EC-UFPs) on allergic airway inflammation. Methods: Ovalbumin-sensitized mice were exposed to EC-UFPs (504 mu g/m(3) for 24 h) or filtered air immediately before allergen challenge and systemically treated with N-acetylcysteine or vehicle before and during EC-UFP inhalation. Allergic inflammation was measured up to 1 week after allergen challenge by means of bronchoalveolar lavage, cytokine/total protein assays, lung function, and histology. Isoprostane levels in lung tissue served to measure oxidative stress. Transmission electron microscopy served to localize ECUFPs in lung tissue and both electrophoretic mobility shift assay and immunohistochemistry to quantify/localize nuclear factor-kappa B (NF-kappa B) activation. Measurements and Main Results: In sensitized and challenged mice EC-UFP inhalation increased allergen-induced lung lipid peroxidation and NF-kappa B activation in addition to inflammatory infiltrate, cytokine release, and airway hyperresponsiveness. Prominent NF-kappa B activation was observed in the same cell types in which EC-UFPs were detected. N-acetylcysteine treatment significantly reduced the adjuvant activity of EC-UFPs. In nonsensitized or sensitized but not challenged mice EC-UFP exposure induced a moderate increase in isoprostanes but no significant effect on other parameters of lung inflammation. Conclusions: Our findings demonstrate a critical role for oxidative stress in EC-UFP-induced augmentation of allergen-induced lung inflammation, where EC-UFP exposure has potentiating effects in lung allergic inflammation. Our data support the concept that allergic individuals are more susceptible to the adverse health effects of EC-UFPs.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
9.792
4.380
57
84
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
air pollution; particulate matter; allergy; oxidative stress; kappa-b activation; diesel exhaust particles; particulate air-pollution; n-acetylcysteine; adjuvant activity; in-vivo; redox regulation; carbon-black; urban air; asthma
Sprache
englisch
Veröffentlichungsjahr
2009
HGF-Berichtsjahr
2009
ISSN (print) / ISBN
1073-449X
e-ISSN
1535-4970
Quellenangaben
Band: 179,
Heft: 11,
Seiten: 984-991
Verlag
American Thoracic Society
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Lung Health and Immunity (LHI)
Institute of Epidemiology (EPI)
Research Unit Signaling and Translation (SAT)
Institute of Epidemiology (EPI)
Research Unit Signaling and Translation (SAT)
POF Topic(s)
30202 - Environmental Health
30203 - Molecular Targets and Therapies
30203 - Molecular Targets and Therapies
Forschungsfeld(er)
Lung Research
Enabling and Novel Technologies
Lung Research
Enabling and Novel Technologies
PSP-Element(e)
G-521200-001
FE 73991
G-505000-001
G-509800-002
G-505000-002
G-505000-004
FE 73991
G-505000-001
G-509800-002
G-505000-002
G-505000-004
Scopus ID
66249129345
PubMed ID
19264975
Erfassungsdatum
2009-07-09